People living with migraine may encounter a wide range of treatment options, making it useful to understand how different medicines work and what they are intended to do. Zavzpret is an acute migraine treatment that belongs to the CGRP receptor antagonist class. It is administered as a nasal spray and is indicated for adults experiencing migraine with or without aura.
Migraine treatments can generally be considered as acute or preventive therapies. Acute treatments are taken to address an attack, while preventive therapies aim to reduce the frequency or severity of future attacks.
Zavzpret is an acute treatment.
Its characteristics include:
Healthcare professionals can help patients understand which treatment approaches may fit their circumstances.
Important considerations can include:
Keeping track of migraine symptoms can help provide useful information during healthcare appointments.
Zavzpret is one of several approaches available for acute migraine treatment. Understanding its CGRP based mechanism and nasal delivery can help readers better understand where it fits within migraine management. Appropriate medical guidance is essential before starting or changing treatment.